Fortunately, the elderly, including those with mild cognitive impairment and mild forms of AD, are able to take up ketone bodies, like β-hydroxybutyrate (BHB) and acetoacetate, through insulin independent monocarboxylate transporters (Cunnane et al., 2016). Here, INS is linked to Alzheimer disease.